Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
Vidya H Veldore,1,* Anuradha Choughule,2,* Tejaswi Routhu,1 Nitin Mandloi,1 Vanita Noronha,2 Amit Joshi,2 Amit Dutt,3 Ravi Gupta,1 Ramprasad Vedam,1 Kumar Prabhash2 1MedGenome Labs Private Ltd,, Bangalore, India; 2Tata Memorial Centre, Parel, Mumbai, India; 3The Advanced Centre for Treatment, Resear...
Saved in:
Main Authors: | Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/75a83c5f0528444c8a9f3e281fae022b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma
by: Kate I. Glennon, et al.
Published: (2021) -
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
by: Natasha Honoré, et al.
Published: (2021) -
BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer
by: Maha Elazezy, et al.
Published: (2021) -
Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors
by: Lionel Larribère, et al.
Published: (2021) -
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis
by: Kate S, et al.
Published: (2019)